Literature DB >> 32855188

MRI Spectrum of Brain Involvement in Sphingosine-1-Phosphate Lyase Insufficiency Syndrome.

K W Martin1, N Weaver2, K Alhasan3, E Gumus4, B R Sullivan5,6, M Zenker7, F Hildebrandt8, J D Saba9.   

Abstract

SGPL1 encodes sphingosine-1-phosphate lyase, the final enzyme of sphingolipid metabolism. In 2017, a condition featuring steroid-resistant nephrotic syndrome and/or adrenal insufficiency associated with pathogenic SGPL1 variants was reported. In addition to the main features of the disease, patients often exhibit a range of neurologic deficits. In a handful of cases, brain imaging results were described. However, high-quality imaging results and a systematic analysis of brain MR imaging findings associated with the condition are lacking. In this study, MR images from 4 new patients and additional published case reports were reviewed by a pediatric neuroradiologist. Analysis reveals recurring patterns of features in affected patients, including isolated callosal dysgenesis and prominent involvement of the globus pallidus, thalamus, and dentate nucleus, with progressive atrophy and worsening of brain lesions. MR imaging findings of abnormal deep gray nuclei, microcephaly, or callosal dysgenesis in an infant or young child exhibiting other typical clinical features of sphingosine-1-phosphate lyase insufficiency syndrome should trigger prompt genetic testing for SGPL1 mutations.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32855188      PMCID: PMC7661081          DOI: 10.3174/ajnr.A6746

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency.

Authors:  Nikolaos Settas; Rebecca Persky; Fabio R Faucz; Nicole Sheanon; Antonis Voutetakis; Maya Lodish; Louise A Metherell; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

2.  Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy.

Authors:  Derek Atkinson; Jelena Nikodinovic Glumac; Bob Asselbergh; Biljana Ermanoska; David Blocquel; Regula Steiner; Alejandro Estrada-Cuzcano; Kristien Peeters; Tinne Ooms; Els De Vriendt; Xiang-Lei Yang; Thorsten Hornemann; Vedrana Milic Rasic; Albena Jordanova
Journal:  Neurology       Date:  2017-01-11       Impact factor: 9.910

Review 3.  Secrets and lyase: Control of sphingosine 1-phosphate distribution.

Authors:  Dhaval Dixit; Martyna Okuniewska; Susan R Schwab
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

4.  Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.

Authors:  Thomas Klopstock; Fernando Tricta; Lynne Neumayr; Ivan Karin; Giovanna Zorzi; Caroline Fradette; Tomasz Kmieć; Boriana Büchner; Hannah E Steele; Rita Horvath; Patrick F Chinnery; Anna Basu; Clemens Küpper; Christiane Neuhofer; Bernadette Kálmán; Petr Dušek; Zuhal Yapici; Ian Wilson; Feng Zhao; Federica Zibordi; Nardo Nardocci; Christine Aguilar; Susan J Hayflick; Michael Spino; Andrew M Blamire; Penelope Hogarth; Elliott Vichinsky
Journal:  Lancet Neurol       Date:  2019-07       Impact factor: 44.182

5.  A novel mutation in sphingosine-1-phosphate lyase causing congenital brain malformation.

Authors:  Daniel Bamborschke; Matthias Pergande; Kerstin Becker; Friederike Koerber; Jörg Dötsch; Anne Vierzig; Lutz T Weber; Sebahattin Cirak
Journal:  Brain Dev       Date:  2018-03-02       Impact factor: 1.961

Review 6.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.

Authors:  Youn-Jeong Choi; Julie D Saba
Journal:  Adv Biol Regul       Date:  2018-09-25

Review 7.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

8.  Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons.

Authors:  Nadine Hagen; Paul P Van Veldhoven; Richard L Proia; Hyejung Park; Alfred H Merrill; Gerhild van Echten-Deckert
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

9.  Responsiveness of sphingosine phosphate lyase insufficiency syndrome to vitamin B6 cofactor supplementation.

Authors:  Piming Zhao; Isaac D Liu; Jeffrey B Hodgin; Peter I Benke; Jeremy Selva; Federico Torta; Markus R Wenk; James A Endrizzi; Olivia West; Weixing Ou; Emily Tang; Denise Li-Meng Goh; Stacey Kiat-Hong Tay; Hui-Kim Yap; Alwin Loh; Nicole Weaver; Bonnie Sullivan; Austin Larson; Megan A Cooper; Khalid Alhasan; Abdullah A Alangari; Suha Salim; Evren Gumus; Karin Chen; Martin Zenker; Friedhelm Hildebrandt; Julie D Saba
Journal:  J Inherit Metab Dis       Date:  2020-05-04       Impact factor: 4.982

10.  SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production.

Authors:  Daniel N Mitroi; Indulekha Karunakaran; Markus Gräler; Julie D Saba; Dan Ehninger; María Dolores Ledesma; Gerhild van Echten-Deckert
Journal:  Autophagy       Date:  2017-05-04       Impact factor: 16.016

View more
  9 in total

1.  A rare cause of nephrotic syndrome-sphingosine-1-phosphate lyase (SGPL1) deficiency: 6 cases and a review of the literature.

Authors:  Tugba Tastemel Ozturk; Nur Canpolat; Seha Saygili; Umut Selda Bayrakci; Oguz Soylemezoglu; Fatih Ozaltin; Rezan Topaloglu
Journal:  Pediatr Nephrol       Date:  2022-06-24       Impact factor: 3.714

2.  A rare cause of nephrotic syndrome - sphingosine-1-phosphate lyase (SGPL1) deficiency: 2 cases.

Authors:  Ana Paula Spizzirri; Carlos José Cobeñas; Angela Del Carmen Suarez
Journal:  Pediatr Nephrol       Date:  2022-08-23       Impact factor: 3.651

Review 3.  Congenital adrenal calcifications as the first clinical indication of sphingosine lyase insufficiency syndrome: A case report and review of the literature.

Authors:  Hayley A Ron; Rebecca Scobell; Amy Strong; Elizabeth G Salazar; Rebecca Ganetzky
Journal:  Am J Med Genet A       Date:  2022-08-16       Impact factor: 2.578

4.  Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Answers.

Authors:  Georgie Mathew; M S Yasmeen; R V Deepthi; Meenakshi Swain; Avinash Vattam; Mehul A Shah; Indira Agarwal
Journal:  Pediatr Nephrol       Date:  2022-01-09       Impact factor: 3.651

5.  Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome.

Authors:  Piming Zhao; Gizachew B Tassew; Joanna Y Lee; Babak Oskouian; Denise P Muñoz; Jeffrey B Hodgin; Gordon L Watson; Felicia Tang; Jen-Yeu Wang; Jinghui Luo; Yingbao Yang; Sarah King; Ronald M Krauss; Nancy Keller; Julie D Saba
Journal:  JCI Insight       Date:  2021-04-22

6.  Insights From Long-term Follow-up of a Girl With Adrenal Insufficiency and Sphingosine-1-Phosphate Lyase Deficiency.

Authors:  Avinaash Maharaj; Tülay Güran; Federica Buonocore; John C Achermann; Louise Metherell; Rathi Prasad; Semra Çetinkaya
Journal:  J Endocr Soc       Date:  2022-02-11

Review 7.  A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review.

Authors:  Avinaash Maharaj; Ruth Kwong; Jack Williams; Christopher Smith; Helen Storr; Ruth Krone; Debora Braslavsky; Maria Clemente; Nanik Ram; Indraneel Banerjee; Semra Çetinkaya; Federica Buonocore; Tülay Güran; John C Achermann; Louise Metherell; Rathi Prasad
Journal:  Endocr Connect       Date:  2022-07-25       Impact factor: 3.221

Review 8.  Neurological Consequences of Sphingosine Phosphate Lyase Insufficiency.

Authors:  Krishan B Atreya; Julie D Saba
Journal:  Front Cell Neurosci       Date:  2022-09-14       Impact factor: 6.147

Review 9.  Genotype/Phenotype Interactions and First Steps Toward Targeted Therapy for Sphingosine Phosphate Lyase Insufficiency Syndrome.

Authors:  Julie D Saba; Nancy Keller; Jen-Yeu Wang; Felicia Tang; Avi Slavin; Yizhuo Shen
Journal:  Cell Biochem Biophys       Date:  2021-06-16       Impact factor: 2.194

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.